Search research articles
Contact Us
Filters
Showing results (171-180 of 296) with videos related to
Page
of 30
Sort By:
Current Microbiology
|
October 24, 2025
HERV-K Envelope Induce a Humoral Response in Non-Hodgkin Lymphoma Patients
Ilaria Cossu, Stefano Ruberto, Elisabetta Filippi, et al.
Frontiers in Systems Neuroscience
|
August 10, 2019
Scaling of a Large-Scale Simulation of Synchronous Slow-Wave and Asynchronous Awake-Like Activity of a Cortical Model With Long-Range Interconnections
Elena Pastorelli, Cristiano Capone, Francesco Simula, et al.
The American Journal of Physiology
|
March 1, 1995
Influence of normal aging on oral-pharyngeal and upper esophageal sphincter function during swallowing
D W Shaw, I J Cook, M Gabb, et al.
Vaccines
|
May 7, 2025
Human Endogenous Retroviruses as Novel Therapeutic Targets in Neurodegenerative Disorders
Elena Rita Simula, Seyedesomaye Jasemi, Davide Cossu, et al.
Brain and Behavior
|
June 29, 2022
Grey matter atrophy in patients with benign multiple sclerosis
Marja Niiranen, Juha Koikkalainen, Jyrki Lötjönen, et al.
Journal of Chemical Theory and Computation
|
May 13, 2025
Transcorrelated Theory with Pseudopotentials
Kristoffer Simula, Evelin Martine Corvid Christlmaier, Maria-Andreea Filip, et al.
Recent Patents on DNA & Gene Sequences
|
December 17, 2008
Recent patents relating to HCV molecules like putative targets for therapeutic intervention
Valli De Re, Domenico Sansonno, Paolo De Paoli, et al.
Archives Italiennes De Biologie
|
March 1, 1996
Trigeminal motoneuron responses to vestibular stimulation in the guinea pig
E Tolu, M A Caria, G Chessa, et al.
Placenta
|
August 26, 2020
Chronic Intervillositis of Unknown Etiology (CIUE): Prevalence, patterns and reproductive outcomes at a tertiary referral institution
Natasha K Simula, Jefferson Terry, Nancy E Kent, et al.
Multiple Sclerosis and Related Disorders
|
June 24, 2020
Corrigendum to "Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation" [Multiple Sclerosis and Related Disorders 38 (2020) 101498]
Tiina Mustonen, Ilkka Rauma, Päivi Hartikainen, et al.
Page
of 30
Search research articles
Search
Showing results (171-180 of 296) with videos related to
Sort By:
Page
of 30
Current Microbiology
|
October 24, 2025
HERV-K Envelope Induce a Humoral Response in Non-Hodgkin Lymphoma Patients
Ilaria Cossu, Stefano Ruberto, Elisabetta Filippi, et al.
Frontiers in Systems Neuroscience
|
August 10, 2019
Scaling of a Large-Scale Simulation of Synchronous Slow-Wave and Asynchronous Awake-Like Activity of a Cortical Model With Long-Range Interconnections
Elena Pastorelli, Cristiano Capone, Francesco Simula, et al.
The American Journal of Physiology
|
March 1, 1995
Influence of normal aging on oral-pharyngeal and upper esophageal sphincter function during swallowing
D W Shaw, I J Cook, M Gabb, et al.
Vaccines
|
May 7, 2025
Human Endogenous Retroviruses as Novel Therapeutic Targets in Neurodegenerative Disorders
Elena Rita Simula, Seyedesomaye Jasemi, Davide Cossu, et al.
Brain and Behavior
|
June 29, 2022
Grey matter atrophy in patients with benign multiple sclerosis
Marja Niiranen, Juha Koikkalainen, Jyrki Lötjönen, et al.
Journal of Chemical Theory and Computation
|
May 13, 2025
Transcorrelated Theory with Pseudopotentials
Kristoffer Simula, Evelin Martine Corvid Christlmaier, Maria-Andreea Filip, et al.
Recent Patents on DNA & Gene Sequences
|
December 17, 2008
Recent patents relating to HCV molecules like putative targets for therapeutic intervention
Valli De Re, Domenico Sansonno, Paolo De Paoli, et al.
Archives Italiennes De Biologie
|
March 1, 1996
Trigeminal motoneuron responses to vestibular stimulation in the guinea pig
E Tolu, M A Caria, G Chessa, et al.
Placenta
|
August 26, 2020
Chronic Intervillositis of Unknown Etiology (CIUE): Prevalence, patterns and reproductive outcomes at a tertiary referral institution
Natasha K Simula, Jefferson Terry, Nancy E Kent, et al.
Multiple Sclerosis and Related Disorders
|
June 24, 2020
Corrigendum to "Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation" [Multiple Sclerosis and Related Disorders 38 (2020) 101498]
Tiina Mustonen, Ilkka Rauma, Päivi Hartikainen, et al.
Page
of 30